Oakland, CA, United States of America

Kristi J Humphreys

This inventor holds 1 USPTO granted patent. Top assignee: University System of Maryland. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kristi J Humphreys. Retrieved from https://idiyas.com/inventor/kristi-j-humphreys

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Kristi J Humphreys

Introduction

Kristi J Humphreys is an accomplished inventor based in Oakland, CA. She has made significant contributions to the field of cancer treatment through her innovative research. Her work focuses on the development of novel compounds that can effectively target and treat cancer cells.

Latest Patents

Kristi J Humphreys holds a patent for a dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment. This invention relates to a novel method for splitting nucleic acids at specific points on a complementary nucleic acid segment using a dinuclear copper-based compound of Formula I. Additionally, it presents a new treatment for cancer, tumors, and cancer cells utilizing this compound or a naked ligand of Formula II.

Career Highlights

Kristi is affiliated with the University System of Maryland, where she conducts her research and develops her innovative solutions. Her dedication to advancing cancer treatment has positioned her as a key figure in her field.

Collaborations

Throughout her career, Kristi has collaborated with notable colleagues, including Lei Li and Kenneth D Karlin. These partnerships have enhanced her research and contributed to the success of her inventions.

Conclusion

Kristi J Humphreys exemplifies the spirit of innovation in the medical field, particularly in cancer treatment. Her work continues to pave the way for new therapeutic approaches that could significantly impact patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…